15,831 reports of this reaction
1.5% of all ACETAMINOPHEN reports
#14 most reported adverse reaction
ASTHENIA is the #14 most commonly reported adverse reaction for ACETAMINOPHEN, manufactured by Kenvue Brands LLC. There are 15,831 FDA adverse event reports linking ACETAMINOPHEN to ASTHENIA. This represents approximately 1.5% of all 1,089,938 adverse event reports for this drug.
Patients taking ACETAMINOPHEN who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is a less commonly reported adverse event for ACETAMINOPHEN, but still significant enough to appear in the safety profile.
In addition to asthenia, the following adverse reactions have been reported for ACETAMINOPHEN:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 15,831 FDA reports for ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 1.5% of all adverse event reports for ACETAMINOPHEN, making it a notable side effect.
If you experience asthenia while taking ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.